Pricing Log in Create free account

Fortrea Holdings Inc. (FTRE) vs Disc Medicine, Inc. (IRON)

Fortrea Holdings Inc. and Disc Medicine, Inc. are both Biotechnology companies. Fortrea Holdings Inc. and Disc Medicine, Inc. are of similar size ($2.2B and $2.2B). Disc Medicine, Inc. has the higher net margin (0.00% vs −3.18%) and the higher return on invested capital (0.00% vs −0.48%). Across the 14 metrics below, Disc Medicine, Inc. leads on 8 and Fortrea Holdings Inc. on 6.

Valuation

Metric FTRE IRON Biotechnology median
P/E n/m n/m 8.50
P/S 0.80 n/m 9.71
P/B 4.07 3.41 2.13
Price to free cash flow 10.77 n/m 20.82
EV/EBITDA 44.71 n/m 0.64
EV/Sales 1.13 n/m 9.21
Earnings yield (4.05%) (11.58%) (33.15%)
Free cash flow yield 9.29% (9.03%) (25.50%)

Profitability

Metric FTRE IRON Biotechnology median
Gross margin 19.30% 0.00% 65.16%
Operating margin (0.40%) 0.00% 0.00%
Net margin (3.18%) 0.00% 0.00%
Free cash flow margin 7.40% 0.00% 0.00%
Return on equity (15.30%) (39.08%) (56.36%)
Return on assets (3.07%) (35.12%) (48.04%)
Return on invested capital (0.48%) 0.00% 0.00%

Growth

Metric FTRE IRON Biotechnology median
Revenue growth (TTM) (2.09%) — 6.02%
EPS growth (last fiscal year) (194.55%) (51.77%) 30.26%
Revenue growth, 5-year CAGR 1.09% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FTRE IRON Biotechnology median
Debt to equity 2.01 0.09 0.00
Current ratio 0.96 24.14 4.72
Net debt to EBITDA 266.13 3.12 0.96

Dividend

Metric FTRE IRON Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric FTRE IRON Biotechnology median
Market cap 2.16b 2.17b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack